Company intelligence / Profile preview

Esper Bionics

Ownership: Private
Development stage: Commercial

Overview

Esper Bionics has commercialized the "Esper Hand," an AI-driven bionic prosthetic hand with FDA and PDAC approval in the US. The device uses advanced EMG sensors and machine learning algorithms to provide intuitive control that adapts to user behavior. Clinical demonstrations have been conducted in several US clinics. The company has also launched a second-generation product ("Esper Hand 2") with waterproofing and further improvements.

Therapeutic areas: OtherNeurology
Modalities: Device
Industry: Assistive Medical Devices

Partnerships

None specifically disclosed; works with partner clinics in New York area for beta testinginsurance partnerships for reimbursement in the USgovernment/donor partnerships for Ukraine humanitarian program

Beyond the preview

Go deeper on Esper Bionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esper Bionics.

Explore the full profile